Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | PGD | P52209 | 3/20 | 0.42 |
| ▸ | MPI | P34949 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.39 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL7862897 | 0.92 | PGK1 (0.39) | PGK1PGK2PGDMPIENPP2 | |
| Ethylene Glycol SCHEMBL10878300 | 0.92 | PGK1 (0.39) | PGK1PGK2PGDMPIENPP2 | |
| Ethylene Glycol SCHEMBL4585430 | 0.92 | PGK1 (0.39) | PGK1PGK2PGDMPIENPP2 | |
| SCHEMBL18132325 | 0.84 | PGK1 (0.34) | PGK1PGK2PGDMPIENPP2 | |
| SCHEMBL8407485 | 0.81 | SMPD1 (0.36) | PGK1PGK2ENPP2LPAR5LPAR1 | |
| SCHEMBL5432672 | 0.81 | SMPD1 (0.36) | PGK1PGK2 | |
| SCHEMBL13636101 | 0.81 | SMPD1 (0.36) | PGK1PGK2ENPP2LPAR5LPAR1 | |
| SCHEMBL10952742 | 0.81 | PGK1 (0.45) | PGK1PGK2PGDMPIENPP2 | |
| SCHEMBL23884557 | 0.79 | PGK1 (0.43) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL25747608 | 0.78 | PGK1 (0.46) | PGK1PGK2PGDMPILPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332268-A1 | CONJUGATE AND COMPOSITION AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | Suzhou Ribo Life Science Co., Ltd. (CN) | 2025-10-30 | — | — | US | claimed |
| WO-2025077871-A1 | CONJUGATE, DRUG CONJUGATE AND COMPOSITION, AND PREPARATION METHOD AND USE | 苏州瑞博生物技术股份有限公司 | 2025-04-17 | — | — | WO | claimed |
| CN-119818695-A | Use of conjugates in medicaments for diagnosing or treating colorectal cancer and related diseases | 苏州瑞博生物技术股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119818694-A | Use of conjugates in medicaments for diagnosing or treating triple negative breast cancer and related diseases | 苏州瑞博生物技术股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| EP-4509139-A1 | CONJUGATE AND COMPOSITION AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | Suzhou Ribo Life Science Co., Ltd. (CN) | 2025-02-19 | — | — | EP | claimed |
| CN-118290926-B | Halogen-free flame-retardant polyurethane cable sheath material and preparation method thereof | 上海皆利新材料科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118475374-A | Aptamer, conjugate, composition, preparation method and application | 苏州瑞博生物技术股份有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-118434450-A | Conjugate, pharmaceutical composition containing conjugate, preparation method and application | 苏州瑞博生物技术股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-118290926-A | Halogen-free flame-retardant polyurethane cable sheath material and preparation method thereof | 上海皆利新材料科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2023198200-A9 | CONJUGATE AND COMPOSITION AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州瑞博生物技术股份有限公司 | 2024-01-11 | — | — | WO | claimed |
| US-11655378-B2 | Electroactive polymer solution comprising conjugated heteroaromatic polymer, electroactive coating comprising the same, and objects comprising electroactive coating | POLYM TECHNOLOGY CORPORATION (TW) | 2023-05-23 | — | — | US | claimed |
| CN-114976003-A | Fluorine-free binder and preparation method and application thereof | 蜂巢能源科技(马鞍山)有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-114605289-A | Carbamate compound for non-aqueous electrolyte and application thereof | 湖州师范学院 | 2022-06-10 | — | — | CN | claimed |
| CN-112038697-A | Lithium ion battery non-aqueous electrolyte and lithium ion battery | 香河昆仑化学制品有限公司 | 2020-12-04 | — | — | CN | claimed |
| CN-109467659-B | Molecularly imprinted microspheres and application method thereof | 中南林业科技大学 | 2020-11-24 | — | — | CN | claimed |
| CN-105070849-B | A kind of light emitting diode with quantum dots and preparation method thereof | TCL集团股份有限公司 | 2018-09-18 | — | — | CN | claimed |
| CN-108409273-A | A kind of building fire protection heat-insulating heat-preserving material and preparation method thereof | 合肥金云新材料有限公司 | 2018-08-17 | — | — | CN | claimed |
| CN-105185918-A | Quantum dot light-emitting layer, preparation method thereof and QLED | TCL GROUP CO LTD | 2015-12-23 | — | — | CN | claimed |
| CN-105070849-A | Light-emitting device with compactly arranged quantum dot light-emitting layer and preparation method thereof | TCL GROUP CO LTD | 2015-11-18 | — | — | CN | claimed |
| EP-1162959-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC GLYCEROPHOSPHATES AND ANALOGS THEREOF FOR PROMOTING NEURAL CELL DIFFERENTIATION | YEDA RES & DEV (IL) | 2005-03-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332268-A1 | CONJUGATE AND COMPOSITION AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | HADHB, LITAF, EZR | PGK1 4367/4885PGK2 4147/4885PGD 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.